A Comparative Study of Characteristics and Outcomes of Patients with Proved and Suggested Sarcoid Uveitis Occurring after Ophthalmic Procedure
Table 2
Treatment of patients with postophthalmic procedure sarcoid uveitis.
Patient
Initial treatment
Outcome of sarcoidosis after initial treatment
Adverse effects of treatment
Subsequent treatment
Final outcome
Final visual acuity
Treatment at the end of follow-up
Follow-up duration (months)
Ophthalmic outcome
Other manifestations
OR
OS
1
Topical CS
CSME OS
No
Systemic CS
Atrophic MFC
Pulmonary nodules progression on CT scan
20/20
20/25
Systemic CS 5 mg/day
52
2
DXM intravitreal implant
No
Systemic CS
CSME
20/50
20/25
Systemic CS 1 mg/day
36
3
DXM intravitreal implant
CSME OR with vitreomacular traction
No
Pars plana vitrectomy with membrane peel
No CSME
0
20/200
No
3
4
Systemic CS 70 mg/day
Retinal vasculitis OU CSME papilledema
No
No
ERM, and no inflammation
20/20
20/25
Systemic CS 4 mg/day
37
5
Topical + systemic CS 20 mg/day
Osteopenia, skin fragility cushing-like syndrome, and CS dependency
No
Persistent bilateral KP, and no posterior inflammation
20/40
20/40
Topical CS
60
6
Topical + systemic CS 20 mg/day
Complete response several relapses: Vitritis OU
Cushing-like syndrome, osteopenia, skin fragility, and CS dependency
MTX
Anterior and intermediate inflammation
Pulmonary embolism
20/20
20/20
Systemic CS 9 mg/day + MTX 10 mg/week
53
7
Topical CS
Vitritis OR peripheral diffuse choroiditis atrophy
No
Systemic CS 40 mg
Vitritis OR persistent
—
—
Subconjunctival injections of triamcinolone
13
8
DXM intravitreal implant
Improvement of CSME
No
No
No inflammation
20/20
20/25
No
15
9
Topical CS
Complete response
No
No
No inflammation
No
19
10
Topical CS
Complete response
No
None
Papilledema
Chest pain
0
20/20
No
11
11
Topical CS
Complete response
No
Dexamethasone intravitreal implant
Recurrent CSME
20/50
20/25
40
CSME = Macular edema, OD = right eye, OS = left eye, OU = both eyes, MFC = multifocal choroiditis, ERM = epiretinal membrane, CT = computed tomography, MTX = methotrexate, and CS = corticosteroids.
